Paediatric myasthenia gravis: Prognostic factors for drug free remission
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (2) , 120-127
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Presence and Pathogenic Relevance of Antibodies to Clustered Acetylcholine Receptor in Ocular and Generalized Myasthenia GravisArchives of Neurology, 2012
- Myasthenia gravis in Jamaican children: a 12-year institutional reviewPaediatrics and International Child Health, 2012
- Visual and Systemic Outcomes in Pediatric Ocular Myasthenia GravisAmerican Journal of Ophthalmology, 2010
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008
- Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in childrenDevelopmental Medicine & Child Neurology, 2008
- Childhood myasthenia: clinical subtypes and practical managementDevelopmental Medicine & Child Neurology, 2007
- Myasthenia gravisNeurology, 2000
- Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravisNeurology, 1994
- Myasthenia gravisNeurology, 1987
- Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescenceNeurology, 1960